Don't Just Read the News, Understand It.
Get Started
SubscribeLogin
Israel-Hamas Conflict
Heatwaves
Independence Day
Artificial Intelligence
Social Media
Senate
Republican Party
Donald Trump
US Politics
Taxes
NHL
Democratic Party
Education
Published • loading... • Updated

New Therapy Improves Cognition in Down Syndrome Patients

Summary by Ground News
Pulsatile GnRH therapy improves cognitive function and neural connectivity in a small patient group. Seven men with Down syndrome, between 20 and 50 years of age, received one subcutaneous dose of GnRH every two hours for 6 months via a pump placed on the arm. Cognition and olfactory tests as well as MRI exams were performed before and after treatment.

1 Articles

All
Left
Center
1
Right
Sci Tech DailySci Tech Daily
Center

New Therapy Improves Cognition in Down Syndrome Patients

A new treatment has been shown to improve cognitive function. In order to enhance the cognitive abilities of a small sample of Down syndrome patients, an Inserm team at the Lille Neuroscience & Cognition laboratory (Inserm/Université de Lille, Lille University Hospital) has collaborated with t

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sci Tech Daily broke the news in on Saturday, October 1, 2022.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Technology icon

Technology

Science icon

Science

You have read 1 out of your 5 free daily articles.

Join millions of well-informed readers who use Ground to compare coverage, check their news blindspots, and challenge their worldview.

News
For You
SearchBlindspotLocal